Related references
Note: Only part of the references are listed.Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells
Yogesh Goyal et al.
NATURE (2023)
Whole-cell segmentation of tissue images with human-level performance using large-scale data annotation and deep learning
Noah F. Greenwald et al.
NATURE BIOTECHNOLOGY (2022)
Subcellular Detection of SARS-CoV-2 RNA in Human Tissue Reveals Distinct Localization in Alveolar Type 2 Pneumocytes and Alveolar Macrophages
Kofi K. Acheampong et al.
MBIO (2022)
Epithelial-to-mesenchymal-like transition events in melanoma
Dennis Pedri et al.
FEBS JOURNAL (2022)
Intermittent treatment of BRAFV600E melanoma cells delays resistance by adaptive resensitization to drug rechallenge
Andrew J. Kavran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma
Claudia Capparelli et al.
NATURE COMMUNICATIONS (2022)
Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment
Dalia Barkley et al.
NATURE GENETICS (2022)
A cellular hierarchy in melanoma uncouples growth and metastasis
Panagiotis Karras et al.
NATURE (2022)
Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer
Srivatsan Raghavan et al.
CELL (2021)
Genetic screening for single-cell variability modulators driving therapy resistance
Eduardo A. Torre et al.
NATURE GENETICS (2021)
DeepCell Kiosk: scaling deep learning-enabled cellular image analysis with Kubernetes
Dylan Bannon et al.
NATURE METHODS (2021)
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states
Ronan Chaligne et al.
NATURE GENETICS (2021)
Variability within rare cell states enables multiple paths toward drug resistance
Benjamin L. Emert et al.
NATURE BIOTECHNOLOGY (2021)
Toxicity of Combinations of Kinase Pathway Inhibitors to Normal Human Cells in a Three-Dimensional Culture
Pouria Rafsanjani Nejad et al.
SLAS TECHNOLOGY (2021)
Cycling cancer persister cells arise from lineages with distinct programs
Yaara Oren et al.
NATURE (2021)
Human melanocyte development and melanoma dedifferentiation at single-cell resolution
Rachel L. Belote et al.
NATURE CELL BIOLOGY (2021)
UCell: Robust and scalable single-cell gene signature scoring
Massimo Andreatta et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors
Geoffrey Shapiro et al.
INVESTIGATIONAL NEW DRUGS (2020)
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alterations
Aditya Bardia et al.
ONCOLOGIST (2020)
Lineage tracing on transcriptional landscapes links state to fate during differentiation
Caleb Weinreb et al.
SCIENCE (2020)
Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds
Denis L. Jardim et al.
ONCOIMMUNOLOGY (2020)
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
Jenny H. Lee et al.
NATURE COMMUNICATIONS (2020)
Memory Sequencing Reveals Heritable Single-Cell Gene Expression Programs Associated with Distinct Cellular Behaviors
Sydney M. Shaffer et al.
CELL (2020)
EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment
Yaqi Tang et al.
CANCERS (2020)
Massively parallel and time-resolved RNA sequencing in single cells with scNT-seq
Qi Qiu et al.
NATURE METHODS (2020)
Gene regulation gravitates toward either addition or multiplication when combining the effects of two signals
Eric M. Sanford et al.
ELIFE (2020)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
CD271 is a molecular switch with divergent roles in melanoma and melanocyte development
Fabian Filipp et al.
SCIENTIFIC REPORTS (2019)
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
Synnove Nymark Aasen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells' Invasive Abilities
Aleksandra Simiczyjew et al.
FRONTIERS IN PHARMACOLOGY (2019)
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma
Inna Smalley et al.
EBIOMEDICINE (2019)
Toward Minimal Residual Disease-Directed Therapy in Melanoma
Florian Rambow et al.
CELL (2018)
Third-generation in situ hybridization chain reaction: multiplexed, quantitative, sensitive, versatile, robust
Harry M. T. Choi et al.
DEVELOPMENT (2018)
AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma
Qiang Zuo et al.
ONCOGENE (2018)
RNA velocity of single cells
Gioele La Manno et al.
NATURE (2018)
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine et al.
ONCOGENESIS (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal et al.
CELL (2018)
Single-cell mapping of lineage and identity in direct reprogramming
Brent A. Biddy et al.
NATURE (2018)
Rare cell variability and drug- induced reprogramming as a mode of cancer drug resistance
Sydney M. Shaffer et al.
NATURE (2017)
An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues
M. Ryan Corces et al.
NATURE METHODS (2017)
SCENIC: single-cell regulatory network inference and clustering
Sara Aibar et al.
NATURE METHODS (2017)
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma
Robert S. McNeill et al.
NEURO-ONCOLOGY (2017)
Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
Jingsong Zhang et al.
NATURE COMMUNICATIONS (2017)
CD271 determines migratory properties of melanoma cells
Josefine Radke et al.
SCIENTIFIC REPORTS (2017)
NFATc2 is an intrinsic regulator of melanoma dedifferentiation
V. Perotti et al.
ONCOGENE (2016)
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy
Michael P. Smith et al.
CANCER CELL (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
Pedro M. Enriquez-Navas et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Starcode: sequence clustering based on all-pairs search
Eduard Zorita et al.
BIOINFORMATICS (2015)
MITF Modulates Therapeutic Resistance through EGFR Signaling
Zhenyu Ji et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Studying clonal dynamics in response to cancer therapy using high-complexity barcoding
Hyo-eun C. Bhang et al.
NATURE MEDICINE (2015)
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale et al.
SCIENCE SIGNALING (2015)
Using informative Multinomial-Dirichlet prior in a t-mixture with reversible jump estimation of nucleosome positions for genome-wide profiling
Rawane Samb et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2015)
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Annelien Verfaillie et al.
NATURE COMMUNICATIONS (2015)
Using informative Multinomial-Dirichlet prior in a t-mixture with reversible jump estimation of nucleosome positions for genome-wide profiling
Rawane Samb et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2015)
The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma
Rachel Ramsdale et al.
SCIENCE SIGNALING (2015)
PI3K signalling is required for a TGFβ-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells
Natalie C. Schlegel et al.
EXPERIMENTAL DERMATOLOGY (2015)
Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
Chong Sun et al.
NATURE (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance
Meghna Das Thakur et al.
NATURE (2013)
Safety and feasibility of targeted agent combinations in solid tumours
Sook Ryun Park et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Signaling interplay between transforming growth factor-β receptor and PI3K/AKT pathways in cancer
Long Zhang et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma
Maria R. Girotti et al.
CANCER DISCOVERY (2013)
Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
Piyush B. Gupta et al.
CELL (2011)
A Polycomb-based switch underlying quantitative epigenetic memory
Andrew Angel et al.
NATURE (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K
Jessie Villanueva et al.
CANCER CELL (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
flowCore: a Bioconductor package for high throughput flow cytometry
Florian Hahne et al.
BMC BIOINFORMATICS (2009)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
In vivo switching of human melanoma cells between proliferative and invasive states
Keith S. Hoek et al.
CANCER RESEARCH (2008)
Interleukin-6 activates PI3K/Akt pathway and regulates cyclin A1 to promote prostate cancer cell survival
Barbara Wegiel et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Jayne M. Stommel et al.
SCIENCE (2007)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration
AV Bakin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
